Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2011

01-12-2011 | Alkaptonuria

Cardiovascular manifestations of Alkaptonuria

Authors: Stephen J. Pettit, Michael Fisher, James A. Gallagher, Lakshminarayan R. Ranganath

Published in: Journal of Inherited Metabolic Disease | Issue 6/2011

Login to get access

Abstract

The cardiovascular manifestations of alkaptonuria relate to deposition of ochronotic pigment within heart valves, endocardium, aortic intima and coronary arteries. We assessed 16 individuals with alkaptonuria for cardiovascular disease, including full electrocardiographic and echocardiographic assessment. The self reported prevalence of valvular heart disease and coronary artery disease was low. There was a significant burden of previously undiagnosed aortic valve disease, reaching a prevalence of over 40% by the fifth decade of life. The aortic valve disease was found to increase in both prevalence and severity with advancing age. In contrast to previous reports, we did not find a significant burden of mitral valve disease or coronary artery disease. These findings are important for the clinical follow-up of patients with alkaptonuria and suggest a role for echocardiographic surveillance of patients above 40 years old.
Literature
go back to reference Erek E, Casselman FR, Vanermen H (2004) Cardiac ochronosis: valvular heart disease with dark green discoloration of the leaflets. Texas Heart Inst J 31:445–447 Erek E, Casselman FR, Vanermen H (2004) Cardiac ochronosis: valvular heart disease with dark green discoloration of the leaflets. Texas Heart Inst J 31:445–447
go back to reference Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D et al. (1996) The molecular basis of alkaptonuria. Nat Genet 14:19–24PubMedCrossRef Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D et al. (1996) The molecular basis of alkaptonuria. Nat Genet 14:19–24PubMedCrossRef
go back to reference Ffolkes LV, Brull D, Krywawuch S et al (2006) Aortic stenosis in cardiovascular ochronosis. J Clin Pathol 60:92–93CrossRef Ffolkes LV, Brull D, Krywawuch S et al (2006) Aortic stenosis in cardiovascular ochronosis. J Clin Pathol 60:92–93CrossRef
go back to reference Gaines JJ, Pai GM (1987) Cardiovascular ochronosis. Arch Pathol Lab Med 111:991–994PubMed Gaines JJ, Pai GM (1987) Cardiovascular ochronosis. Arch Pathol Lab Med 111:991–994PubMed
go back to reference Goodfellow RJ, Schwartz J, Leya F (2005) Black aorta: a rare finding at aortic valve replacement. J Invasive Cardiol 17:165–167PubMed Goodfellow RJ, Schwartz J, Leya F (2005) Black aorta: a rare finding at aortic valve replacement. J Invasive Cardiol 17:165–167PubMed
go back to reference Gould L, Reddy CVR, Depalwa D (1976) Cardiac manifestations of ochronosis. J Thorac Cardiovasc Surg 72:788–791PubMed Gould L, Reddy CVR, Depalwa D (1976) Cardiac manifestations of ochronosis. J Thorac Cardiovasc Surg 72:788–791PubMed
go back to reference Helliwell TR, Gallagher JA, Ranganath L (2008) Alkaptonuria - a review of surgical and autopsy pathology. Histopathology 53:503–512PubMed Helliwell TR, Gallagher JA, Ranganath L (2008) Alkaptonuria - a review of surgical and autopsy pathology. Histopathology 53:503–512PubMed
go back to reference Lindroos M, Kupari M, Heikkila J (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21:1220–1225PubMedCrossRef Lindroos M, Kupari M, Heikkila J (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21:1220–1225PubMedCrossRef
go back to reference O’Brien WM, La Du BN, Bunim JJ (1963) Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584–1962). Am J Med 34:813–838CrossRef O’Brien WM, La Du BN, Bunim JJ (1963) Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584–1962). Am J Med 34:813–838CrossRef
go back to reference Otto CM, Lind BK, Kitzman DW et al. (1999) Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147PubMedCrossRef Otto CM, Lind BK, Kitzman DW et al. (1999) Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147PubMedCrossRef
go back to reference Phornphutkul C, Introne WJ, Perry MB et al (2002) Natural history of alkaptonuria. N Engl J Med 347:2111–2121PubMedCrossRef Phornphutkul C, Introne WJ, Perry MB et al (2002) Natural history of alkaptonuria. N Engl J Med 347:2111–2121PubMedCrossRef
go back to reference Ranganath L, Taylor AM, Shenkin A et al (2011) Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers. J Inherit Metab Dis. doi:10.1007/s10545-011-9282-z Ranganath L, Taylor AM, Shenkin A et al (2011) Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers. J Inherit Metab Dis. doi:10.​1007/​s10545-011-9282-z
go back to reference Vavuranakis M, Triantafillidi H, Stefanadis C et al (1998) Aortic stenosis and coronary artery disease caused by alkaptonuria, a rare genetic metabolic syndrome. Cardiology 90:302–304PubMedCrossRef Vavuranakis M, Triantafillidi H, Stefanadis C et al (1998) Aortic stenosis and coronary artery disease caused by alkaptonuria, a rare genetic metabolic syndrome. Cardiology 90:302–304PubMedCrossRef
go back to reference Wilke A, Steverding D (2009) Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Reports 3:9302PubMedCrossRef Wilke A, Steverding D (2009) Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Reports 3:9302PubMedCrossRef
go back to reference Yoshikai M, Murayama J, Yameda N (2004) Aortic valve regurgitation in alkaptonuria. J Heart Valve Dis 13:863–865PubMed Yoshikai M, Murayama J, Yameda N (2004) Aortic valve regurgitation in alkaptonuria. J Heart Valve Dis 13:863–865PubMed
go back to reference Zund G, Schmid AC, Vogt PR et al. (1999) Green aortic valve: alcaptonuria (ochronosis) with severe aortic stenosis. Ann Thorac Surg 67:1805PubMedCrossRef Zund G, Schmid AC, Vogt PR et al. (1999) Green aortic valve: alcaptonuria (ochronosis) with severe aortic stenosis. Ann Thorac Surg 67:1805PubMedCrossRef
Metadata
Title
Cardiovascular manifestations of Alkaptonuria
Authors
Stephen J. Pettit
Michael Fisher
James A. Gallagher
Lakshminarayan R. Ranganath
Publication date
01-12-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9339-z

Other articles of this Issue 6/2011

Journal of Inherited Metabolic Disease 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.